Relapsing Remitting Multiple Sclerosis (RRMS)
Also known as: Remitting Relapsing Multiple Sclerosis / Relapse-Remitting Multiple Sclerosis / Relapsing, Remitting Multiple Sclerosis / Multiple Sclerosis (MS) Relapsing Remitting / Relapsing Remitting MS / Multiple Sclerosis - Relapsing Remitting / Multiple Sclerosis, Relapsing Remitting / Relapsing/remitting Multiple sclerosis / Multiple Sclerosis, Relapsing-Remitting / Relapsing-Remitting Multiple Sclerosis (RRMS) / Multiple Sclerosis (Relapsing Remitting) / Relapsing Remitting MS (RRMS) / Relapsing-Remitting Multiple Sclerosis / Multiple Sclerosis, Relapsing, Remitting / Relapsing-Remitting MS / Multiple Sclerosis-Relapsing-Remitting / Remitting-Relapsing Multiple Sclerosis / Relapse Remitting Multiple Sclerosis / Relapsing Remitting Multiple Sclerosis RRMS / Relapsing Remitting Multiple Sclerosis / Multiple Sclerosis (MS) - Relapsing-remitting / RRMS / Relapsing remitting multiple sclerosis (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB00087 | Alemtuzumab | A monoclonal anti-CD52 antibody used in the treatment of B-cell chronic lymphocytic leukemia and relapsing forms of multiple sclerosis. |
DB08908 | Dimethyl fumarate | A medication used to treat patients with the relapsing-remitting form of multiple sclerosis. |
DB14783 | Diroximel fumarate | A drug used for the treatment of relapsing forms of Multiple Sclerosis (MS). |
DB08868 | Fingolimod | A sphingosine 1-phosphate receptor modulator used to treat patients with the relapsing-remitting form of multiple sclerosis (MS) and studied to manage lung complications of COVID-19. |
DB05259 | Glatiramer | An immunomodulator used to reduce the frequency of relapses in Multiple Sclerosis (MS). |
DB14999 | Human interferon beta | A polypeptide drug used in the treatment of relapsing forms of Multiple Sclerosis (MS). |
DB01204 | Mitoxantrone | A chemotherapeutic agent used for the treatment of secondary progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis. |
DB00108 | Natalizumab | A monoclonal anti-integrin antibody used to treat Crohn's disease or multiple sclerosis. |
DB11988 | Ocrelizumab | A CD20 specific monoclonal antibody used to treat relapsing remitting multiple sclerosis. |
DB06650 | Ofatumumab | An anti-CD20 antibody used for the treatment of chronic lymphocytic leukemia (CLL) in selected patients with certain treatment histories and responsiveness to anticancer medications. |
DB12612 | Ozanimod | A sphingosine 1-phosphate receptor modulator being studied to treat Multiple Sclerosis (MS) and inflammatory bowel disease (IBD). |
DB09122 | Peginterferon beta-1a | An interferon beta used to treat relapsing forms of multiple sclerosis. |
DB12016 | Ponesimod | A sphingosine 1-phosphate receptor modulator indicated to treat relapsing multiple sclerosis. |
DB11850 | Ublituximab | A low-fucose CD20-targeted monoclonal antibody used in the treatment of relapsing forms of multiple sclerosis. |